The Latest Breaking News from Andrew Pollard

Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

In under two years, the UK saw the removal of its measles-free status with the UK Health Security Agency (UKHSA) declaring it a national incident.

Spread of virus adds 'extra burden' on NHS amid strikes and rising flu cases

An expert scientific committee advising the British government recommended for the first time Tuesday that children should be immunized with the chickenpox vaccine — decades after the shots were made widely available in other countries, including the U.S., Canada and Australia

Youngsters should be offered two doses when they are aged 12 months and 18 months, scientists have said.

Researchers will also seek ways to speed up manufacture of jabs so vaccines could be rolled out more quickly in the event of a future outbreak.

The UK Health and Security Agency has launched a major research facility to develop vaccines against potentially deadly pathogens.

Pressures on the NHS, a lack of doctors and post-Brexit delays are hampering our ability to develop cutting-edge drugs, says Prof Sir Andrew Pollard, director of the Oxford Vaccine Group

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases